Genetic research
Gene Therapy Shows Promise in Treating Rare Immunity Disorder
Researchers at the University of California, Los Angeles, have made significant progress in developing a gene therapy for X-linked agammaglobulinemia (XLA), a rare inborn error of immunity. According to a new study, published in Molecular Therapy: Methods & Clinical Development, the therapy has shown promising results in treating XLA patients